Loading company…
MicroWash develops a nasal irrigation device that collects specimens for respiratory illness testing.
Founded in 2022, MicroWash is based in Omaha, US, and develops nasal specimen collection devices. Its MicroWash product uses saline irrigation to collect nasopharyngeal samples without swabs for testing for COVID-19, RSV, influenza, and other respiratory illnesses. In February 2024, the company raised USD 1.6 million in seed funding co-led by Bright Minds Capital Partners and Invest Nebraska.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in